|
|
Colonoscopy to Screen for Colorectal Cancer
The use of colonoscopy to screen asymptomatic adults for colorectal cancer
is receiving increasing attention. For example, if distal neoplasms were
detected by sigmoidoscopy, the finding would prompt a colonoscopy. A critical
question concerns the risk of advanced proximal neoplasms in patients without
distal neoplasms. In this study, colonoscopic screening detected many advanced
proximal neoplasms that would not have been detected with sigmoidoscopy
because the patients did not have distal adenomas.
Distal
Colorectal Polyps and the Risk of Advanced Proximal Neoplasms
It is uncertain how best to screen asymptomatic
persons for colorectal cancer. This study determined the relative risk of
advanced proximal neoplasms in persons 50 years of age or older who had
distal polyps, as compared with those who did not have distal polyps. The
authors found that although persons with distal polyps were at increased
risk for advanced proximal neoplasia, about half of all cases would not
have been detected if colonoscopy had been performed only in those with
distal polyps.
Rapid Detection of Group B Streptococci
This
study compared the efficacy of a rapid polymerase-chain-reaction (PCR) assay,
a conventional PCR assay and culture for the detection of group B streptococci
in 112 women at the time of delivery. The sensitivity of both PCR assays
was 97.0 percent, and both had a negative predictive value of 98.8 percent.
The rapid PCR assay (process time, about 1 hour) identifies group B streptococci
in time to allow the institution of antibiotic prophylaxis before delivery
in many women.
Acetylcysteine to Prevent Contrast-AgentInduced Reductions in Renal Function
Radiographic contrast
agents can reduce renal function. This study evaluated the use of acetylcysteine,
which has antioxidant properties, to prevent deterioration of renal function
in patients with renal insufficiency who must undergo scanning with contrast
material. Among 41 patients given acetylcysteine before administration of
the contrast agent, only 2 percent had an increase in the serum creatinine
concentration, as compared with 21 percent of 42 patients given placebo.
|